Si-Bone Inc (SIBN)

Currency in USD
16.00
-1.90(-10.61%)
Closed·
After Hours
16.000.00(0.00%)
·
SIBN Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual trading volume
SIBN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
15.1117.67
52 wk Range
11.7020.05
Key Statistics
Prev. Close
16
Open
17.25
Day's Range
15.11-17.67
52 wk Range
11.7-20.05
Volume
1.79M
Average Volume (3m)
503.26K
1-Year Change
13.96%
Book Value / Share
4
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SIBN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
25.00
Upside
+56.25%
Members' Sentiments
Bearish
Bullish
ProTips
4 analysts have revised their earnings upwards for the upcoming period

Si-Bone Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Si-Bone Inc Company Profile

SI-BONE, Inc., a medical device company, focuses on solving musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. The company offers proprietary minimally invasive surgical implant systems to address sacroiliac joint dysfunction and degeneration, adult deformity and degeneration, and pelvic trauma, as well as implantable bone products. It also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with a proprietary 3D-printed porous surface and fenestrated design; iFuse TORQ, a line of 3D-printed threaded implants designed for applications in pelvic trauma and sacroliliac fusion; and iFuse Bedrock Granite Implant System that provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion; and iFuse TORQ TNT to treat pelvic trauma and sacroiliac joint dysfunction, as well as iFuse INTRA implants that are marketed as human cells, tissues, and cellular or tissue-based products. The company markets its products primarily with a direct sales force, as well as through third-party sales agent and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

Si-Bone Inc SWOT Analysis


Surgical Innovation
SI-BONE's iFuse Implant System revolutionizes sacroiliac joint disorder treatment, driving impressive financial performance and market expansion
Financial Momentum
Explore SI-BONE's robust revenue growth, strong gross margins, and progress towards profitability, with analyst price targets ranging from $19 to $32
Market Dominance
Delve into SI-BONE's expanding surgeon base, product diversification strategy, and regulatory breakthroughs positioning the company as a leader in minimally invasive surgery
Future Prospects
Learn about SI-BONE's ambitious growth plans, including new product launches and potential market expansions, set against a backdrop of increasing insurance coverage
Read full SWOT analysis

Si-Bone Inc Earnings Call Summary for Q2/2025

  • Si-Bone beats Q2 2025 expectations with EPS of -$0.14 and revenue of $48.6M, up 21.7% YoY; stock rises 2.93% after-hours
  • Company reports third consecutive quarter of positive adjusted EBITDA; gross margin expands to 79.8%
  • Full-year revenue guidance set at $195-$198M, projecting 17-18% growth; positive adjusted EBITDA expected to continue
  • Plans to expand sales territories and launch new products in 2026; focus on U.S. market and ASC expansion
  • CEO expresses optimism for H2; CFO projects medium-term gross margin stabilization at 76-77%
Last Updated: 04/08/2025, 22:42
Read Full Transcript

Compare SIBN to Peers and Sector

Metrics to compare
SIBN
Peers
Sector
Relationship
P/E Ratio
−28.7x−11.2x−0.5x
PEG Ratio
−0.66−0.190.00
Price/Book
4.0x2.8x2.6x
Price / LTM Sales
3.7x3.3x3.3x
Upside (Analyst Target)
56.3%76.1%42.8%
Fair Value Upside
Unlock5.3%6.5%Unlock

Analyst Ratings

9 Buy
0 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 25.00
(+56.25% Upside)

Earnings

Latest Release
Aug 04, 2025
EPS / Forecast
-0.14 / -0.18
Revenue / Forecast
48.60M / 46.72M
EPS Revisions
Last 90 days

SIBN Income Statement

People Also Watch

37.46
EXEL
+1.77%
8.05
PAGS
+0.50%
12.85
CDNA
+1.98%
34.94
HRMY
-1.69%
5.62
NEO
-0.88%

FAQ

What Stock Exchange Does Si-Bone Trade On?

Si-Bone is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Si-Bone?

The stock symbol for Si-Bone is "SIBN."

What Is the Si-Bone Market Cap?

As of today, Si-Bone market cap is 681.83M.

What Is Si-Bone's Earnings Per Share (TTM)?

The Si-Bone EPS (TTM) is -0.56.

When Is the Next Si-Bone Earnings Date?

Si-Bone will release its next earnings report on 09 Nov 2025.

From a Technical Analysis Perspective, Is SIBN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Si-Bone Stock Split?

Si-Bone has split 0 times.

How Many Employees Does Si-Bone Have?

Si-Bone has 349 employees.

What is the current trading status of Si-Bone (SIBN)?

As of 06 Aug 2025, Si-Bone (SIBN) is trading at a price of 16.00, with a previous close of 16.00. The stock has fluctuated within a day range of 15.11 to 17.67, while its 52-week range spans from 11.70 to 20.05.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.